Almost half of UK women have had persistent women's health symptoms dismissed by doctors, with only 12% taken seriously at their first appointment, according to a survey.
The study of 2,000 UK-based women, conducted by women-led period and cycle tracker app Clue, found that 45% of women said healthcare professionals had fobbed off their concerns. One-third of respondents experienced this across multiple appointments.
Growing Ownership of Health Data
The findings show how people are taking greater ownership of their health and turning personal data into diagnoses. Almost half of women (45%) have taken cycle-tracking or symptom records to medical appointments, rising to 62% of 25 to 34-year-olds.
One in seven (14%) say this personal data directly helped them secure a diagnosis or treatment plan. The study reflects a wider shift in how people understand and talk about their bodies.
Shift in Understanding and Communication
Almost two-thirds (64%) said they feel more comfortable discussing menstrual and hormonal health than they did a decade ago, and 85% now see a connection between their cycle and their overall health.
Much of that knowledge is self-taught, as just 8% said school sex education helped them understand their bodies, compared with 30% who credit social media and 29% who credit tracking apps.
Personal Stories and Community Impact
The report also shares personal stories from Clue's community, from navigating long fertility journeys and achieving motherhood, to recognising symptoms that helped lead to diagnoses of Premenstrual Dysphoric Disorder (PMDD) and endometriosis.
Women also want their experiences to help others. A staggering 75% say they'd feel proud to contribute anonymised cycle-tracking data if it helped future generations receive faster diagnoses.
Findings Released with 10 Years of Science Report
The findings have been released alongside Clue's landmark 10 Years of Science report, which brings together 750 million tracked cycles and 40 published studies.
Clue user Renisa King, who has been using the app for more than a decade, said: "Finally getting a [PMDD] diagnosis meant everything. My experiences were validated and I could finally pursue proper, targeted support to manage my symptoms effectively."
Clue's CEO, Rhiannon White, said: "Over the past decade we've seen an incredible shift in how people talk about and understand their bodies. Conversations that were once kept quiet are now happening openly, and people are using technology, science and shared experiences to better understand their health."
"What's really exciting is that this knowledge doesn't just benefit individuals. Every insight has the potential to contribute to a much bigger picture, helping researchers better understand menstrual and reproductive health and supporting more informed conversations with healthcare professionals."
"Ten years and 750 million cycles later, we're only getting started. Our ambition is to keep turning personal knowledge into scientific progress, giving more people the tools to understand their bodies and help shape a future of better health for everyone."